Figure 3
From: Effects of progranulin on the pathological conditions in experimental myocardial infarction model
Administration of recombinant progranulin decreased infarct size after myocardial infarction in mice. (A) Representative photographs show the heart sections stained by 2, 3, 5-Triphenyl tetrazolium chloride (TTC) solution, 24 h after permanent occlusion of LCA. (B) Quantitative analysis of infarct size 24 h after permanent occlusion of LCA. The administration of recombinant progranulin significantly decreased myocardial infarct size compared with vehicle-treated group. Data are the means ± SEM. (n = 7–9) *p < 0.05 vs. vehicle-treated group (two-tailed Student's t-test).
